查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1881474

分子細胞遺傳學市場－全球產業規模、佔有率、趨勢、機會和預測，按應用、技術、產品、最終用途、地區和競爭格局分類，2020-2030年預測

Molecular Cytogenetics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By Technology, By Product, By End use, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球分子細胞遺傳學市場規模為22.4億美元，預計2030年將以8.33%的複合年成長率成長至36.2億美元。分子細胞遺傳學整合了分子生物學和細胞遺傳學，用於分析染色體結構，主要用於檢測與遺傳疾病和癌症相關的異常。該市場的成長主要受全球遺傳疾病和腫瘤疾病盛行率不斷上升的驅動，這促使人們對精準的診斷工具的需求日益成長。此外，對個人化醫療的需求不斷成長，而個人化醫療則依賴詳細的基因組資訊來制定客製化治療方案，這也顯著推動了市場成長。

市場概覽
預測期 2026-2030
2024年市場規模 22.4億美元
2030年市場規模 36.2億美元
2025-2030年複合年成長率 8.33%
成長最快的細分市場 腫瘤學
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球分子細胞遺傳學市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依應用領域（遺傳疾病、腫瘤學、個人化醫療、其他）
    • 依技術分類（比較基因組雜交、FISH、免疫組織化學核型分析）
    • 依產品分類（儀器、耗材、軟體及服務）
    • 依最終用途（醫院和診所、學術研究機構、製藥和生物技術公司、其他）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美分子細胞遺傳學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲分子細胞遺傳學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區分子細胞遺傳學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲分子細胞遺傳學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲分子細胞遺傳學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球分子細胞遺傳學市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Danaher Corporation
  • MetaSystems International
  • Agilent Technologies, Inc.
  • Abbott Laboratories, Inc.
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • Oxford Gene Technology IP Limited
  • F. Hoffmann-La Roche Ltd
  • PerkinElmer Inc.
  • BIOVIEW Ltd.

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 22158

The Global Molecular Cytogenetics Market, valued at USD 2.24 Billion in 2024, is projected to experience a CAGR of 8.33% to reach USD 3.62 Billion by 2030. Molecular cytogenetics integrates molecular biology and cytogenetics to analyze chromosome structure, primarily for detecting abnormalities linked to genetic disorders and cancer. This market's expansion is fundamentally driven by the increasing global prevalence of genetic conditions and oncological diseases, necessitating precise diagnostic tools. The growing demand for personalized medicine, which relies on detailed genomic insights for tailored therapies, also significantly propels market growth.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.24 Billion
Market Size 2030USD 3.62 Billion
CAGR 2025-20308.33%
Fastest Growing SegmentOncology
Largest MarketNorth America

Key Market Drivers

The global molecular cytogenetics market is significantly influenced by the escalating incidence of cancer and genetic disorders worldwide. These pervasive health challenges necessitate highly precise and comprehensive diagnostic tools, directly driving the demand for molecular cytogenetic techniques capable of detecting chromosomal abnormalities and genetic variations. Such advanced diagnostic capabilities are crucial for early detection, accurate prognosis, and effective treatment planning in oncology and inherited conditions.

Key Market Challenges

The high cost of advanced molecular cytogenetics instrumentation and the specialized expertise required for complex testing procedures represent a significant barrier to market expansion. This financial burden restricts the widespread adoption of these sophisticated diagnostic tools, particularly in regions with developing healthcare infrastructures that face challenges with substantial upfront capital investments and ongoing operational expenses. Acquiring and maintaining state-of-the-art equipment, alongside recruiting and retaining highly skilled personnel, places considerable strain on laboratory budgets.

Key Market Trends

The increasing integration of Artificial Intelligence and automation is fundamentally transforming cytogenetic workflows by enhancing efficiency and precision. These advanced systems are designed to streamline labor-intensive processes such as image analysis, karyotyping, and the detection of chromosomal abnormalities, thereby reducing manual error rates and accelerating turnaround times. For instance, according to CAP Today, in December 2024, digital pathology, which encompasses AI and automation in image analysis, reflected approximately 10 percent adoption in clinical laboratories, indicating a gradual but steady integration into diagnostic practices.

Key Market Players

  • Danaher Corporation
  • MetaSystems International
  • Agilent Technologies, Inc.
  • Abbott Laboratories, Inc.
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • Oxford Gene Technology IP Limited
  • F. Hoffmann-La Roche Ltd
  • PerkinElmer Inc.
  • BIOVIEW Ltd.

Report Scope:

In this report, the Global Molecular Cytogenetics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Molecular Cytogenetics Market, By Application:

  • Genetic Disorders
  • Oncology
  • Personalized Medicine
  • Others

Molecular Cytogenetics Market, By Technology:

  • Comparative Genomic Hybridization
  • FISH
  • Immunohistochemistry Karyotyping

Molecular Cytogenetics Market, By Product:

  • Instruments
  • Consumables
  • Software & Services

Molecular Cytogenetics Market, By End use:

  • Hospitals & Clinics
  • Academic Research Institutes
  • Pharmaceutical & Biotech Companies
  • Others

Molecular Cytogenetics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Molecular Cytogenetics Market.

Available Customizations:

Global Molecular Cytogenetics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Molecular Cytogenetics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Genetic Disorders, Oncology, Personalized Medicine, Others)
    • 5.2.2. By Technology (Comparative Genomic Hybridization, FISH, Immunohistochemistry Karyotyping)
    • 5.2.3. By Product (Instruments, Consumables, Software & Services)
    • 5.2.4. By End use (Hospitals & Clinics, Academic Research Institutes, Pharmaceutical & Biotech Companies, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America Molecular Cytogenetics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Technology
    • 6.2.3. By Product
    • 6.2.4. By End use
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Molecular Cytogenetics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Product
        • 6.3.1.2.4. By End use
    • 6.3.2. Canada Molecular Cytogenetics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Product
        • 6.3.2.2.4. By End use
    • 6.3.3. Mexico Molecular Cytogenetics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Product
        • 6.3.3.2.4. By End use

7. Europe Molecular Cytogenetics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Technology
    • 7.2.3. By Product
    • 7.2.4. By End use
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Molecular Cytogenetics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Product
        • 7.3.1.2.4. By End use
    • 7.3.2. France Molecular Cytogenetics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Product
        • 7.3.2.2.4. By End use
    • 7.3.3. United Kingdom Molecular Cytogenetics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Product
        • 7.3.3.2.4. By End use
    • 7.3.4. Italy Molecular Cytogenetics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Product
        • 7.3.4.2.4. By End use
    • 7.3.5. Spain Molecular Cytogenetics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Product
        • 7.3.5.2.4. By End use

8. Asia Pacific Molecular Cytogenetics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Technology
    • 8.2.3. By Product
    • 8.2.4. By End use
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Molecular Cytogenetics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Product
        • 8.3.1.2.4. By End use
    • 8.3.2. India Molecular Cytogenetics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Product
        • 8.3.2.2.4. By End use
    • 8.3.3. Japan Molecular Cytogenetics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Product
        • 8.3.3.2.4. By End use
    • 8.3.4. South Korea Molecular Cytogenetics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Product
        • 8.3.4.2.4. By End use
    • 8.3.5. Australia Molecular Cytogenetics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Product
        • 8.3.5.2.4. By End use

9. Middle East & Africa Molecular Cytogenetics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Technology
    • 9.2.3. By Product
    • 9.2.4. By End use
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Molecular Cytogenetics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Product
        • 9.3.1.2.4. By End use
    • 9.3.2. UAE Molecular Cytogenetics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Product
        • 9.3.2.2.4. By End use
    • 9.3.3. South Africa Molecular Cytogenetics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Product
        • 9.3.3.2.4. By End use

10. South America Molecular Cytogenetics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Technology
    • 10.2.3. By Product
    • 10.2.4. By End use
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Molecular Cytogenetics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Product
        • 10.3.1.2.4. By End use
    • 10.3.2. Colombia Molecular Cytogenetics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Product
        • 10.3.2.2.4. By End use
    • 10.3.3. Argentina Molecular Cytogenetics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Product
        • 10.3.3.2.4. By End use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Molecular Cytogenetics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Danaher Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. MetaSystems International
  • 15.3. Agilent Technologies, Inc.
  • 15.4. Abbott Laboratories, Inc.
  • 15.5. Bio-Rad Laboratories, Inc.
  • 15.6. Illumina, Inc.
  • 15.7. Oxford Gene Technology IP Limited
  • 15.8. F. Hoffmann-La Roche Ltd
  • 15.9. PerkinElmer Inc.
  • 15.10. BIOVIEW Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer